Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Geron Corporation

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates
Tickers GERN
From GlobeNewswire News Releases
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 70,000 shares of Geron common stock as an inducement to a newly-hired... 
Tickers GERN
From Business Wire News Releases
Geron Announces Four Imetelstat Presentations at the Virtual Edition of the European Hematology Association Annual Congress
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that four abstracts containing new clinical data and analyses related to imetelstat, the Company’s... 
Tickers GERN
From Business Wire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 500,000 shares of Geron common stock as inducements to two newly-hired... 
Tickers GERN
From Business Wire News Releases
Geron to Present at Needham Virtual Healthcare Conference
Tickers GERN
From GlobeNewswire News Releases
Geron Provides COVID-19 Related Business Update
Tickers GERN
From GlobeNewswire News Releases
Geron Corporation Reports Fourth Quarter and Full Year 2019 Financial Results and 2020 Milestones
Conference Call Scheduled for 4:30 p.m. ET today 
Tickers GERN
From GlobeNewswire News Releases
Geron to Announce Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Geron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2019 financial results after the market closes on Thursday, March 12, 2020 via press release,... 
Tickers GERN
From Business Wire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 100,000 shares of Geron common stock as inducements to two newly-hired... 
Tickers GERN
From Business Wire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 98,000 shares of Geron common stock as inducements to two newly-hired... 
Tickers GERN
From Business Wire News Releases
Geron Announces 2019 Accomplishments and Key Development Priorities for 2020
Geron Corporation (Nasdaq: GERN), a late-stage clinical development biopharmaceutical company, today announced 2019 accomplishments and key development priorities for 2020. The Company is currently... 
Tickers GERN
From Business Wire News Releases
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 100,000 shares of Geron common stock as an inducement to a newly-hired... 
Tickers GERN
From Business Wire News Releases
Geron Reports Two Poster Presentations at American Society of Hematology Annual Meeting
Geron Corporation (Nasdaq: GERN) today announced that two posters related to imetelstat, the Company’s first-in-class telomerase inhibitor, were presented at the 61st American Society of Hematology... 
Tickers GERN
From Business Wire News Releases
Geron Announces Appointment of New Executive to Focus on Corporate Strategy
Geron Corporation (Nasdaq: GERN) today announced the appointment of Anil Kapur as Executive Vice President, Corporate Strategy and Chief Commercial Officer. With this appointment, all functions of a... 
Tickers GERN
From Business Wire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tickers GERN
From GlobeNewswire News Releases
Geron Corporation Reports Third Quarter 2019 Financial Results and Recent Events
Tickers GERN
From GlobeNewswire News Releases
Geron Announces Two Poster Presentations at Upcoming American Society of Hematology Annual Meeting
Tickers GERN
From GlobeNewswire News Releases
Geron to Announce Third Quarter Financial Results on November 6, 2019
Tickers GERN
From GlobeNewswire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tickers GERN
From GlobeNewswire News Releases
Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
Tickers GERN
From GlobeNewswire News Releases
Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis
Tickers GERN
From GlobeNewswire News Releases
Geron to Present at 2019 Cantor Global Healthcare Conference
Tickers GERN
From GlobeNewswire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tickers GERN
From GlobeNewswire News Releases
Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
Tickers GERN
From GlobeNewswire News Releases
Geron Corporation Reports Second Quarter 2019 Financial Results and Recent Events
Tickers GERN
From GlobeNewswire News Releases
Geron to Announce Second Quarter Financial Results on August 1, 2019
Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2019 financial results after the market closes on Thursday, August 1, 2019 via press release, which will be... 
Tickers GERN
From GlobeNewswire News Releases
Geron Enhances Oncology Expertise to Advance Corporate Objectives
Geron Corporation (Nasdaq: GERN) today announced the appointments of Sharon McBain as Vice President, Global Regulatory Affairs and Lynn Bodarky as Vice President, Business Development. These... 
Tickers GERN
From GlobeNewswire News Releases
Geron Appoints Vice President, Human Resources
Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other recently recruited senior leadership to further strengthen the... 
Tickers GERN
From GlobeNewswire News Releases
Geron Reports Two Imetelstat Data Presentations at European Hematology Association Annual Congress
Geron Corporation (Nasdaq: GERN) today announced that an oral and a poster presentation of clinical data and analyses related to imetelstat, the Company’s first-in-class telomerase inhibitor, were made... 
Tickers GERN
From GlobeNewswire News Releases
Geron to Webcast KOL Event on June 25, 2019
Geron Corporation (Nasdaq: GERN) today announced that the Company will webcast an event on June 25, 2019, featuring key opinion leaders (KOLs) who are authors of imetelstat data presentations being... 
Tickers GERN
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback